UNSPSC 51292401: Bifemelane

This classification denotes an antidepressive agent with the molecular formula C18H23NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z4501GN13G, chemically known as 1-butanamine, n-methyl-4-(2-(phenylmethyl)phenoxy)-, hydrochloride but generally known as bifemelane, which bears US NIH Compound Identifier 2377. Bifemelane most often comes in base and hydrochloride forms. European Medicines Agency schedules Bifemelane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05827MIG.

UNSPSC 51292401 Bifemelane is a Commodity code. State and local health authorities are using this code to procure naloxone and drug deactivation systems for community health initiatives, though the code's nominal pharmaceutical classification diverges from the actual scope of work being solicited. Seminole County, Florida solicited naloxone and safe drug deactivation systems through an IFB (Invitation for Bid) in 2023, seeking 1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries. The procurement targets community health support rather than individual pharmaceutical dispensing, and vendors must meet standard compliance requirements including drug-free workplace certification, E-Verify confirmation, and federal adherence when FEMA funding is involved. Issuing bodies under this code include county health departments and similar local public health agencies managing opioid response and harm-reduction programs.

Geographic activity under the code shows limited recent sourcing, with the most visible opportunity in Florida. Seminole County's naloxone and drug deactivation systems IFB (IFB60459723LAS) posted June 30, 2026, with a response deadline of July 26, 2023, required quarterly delivery to the Seminole County Community Health Building in Sanford. The contract offers a two-year initial term plus a one-year renewal option, with pricing submitted on a fixed-fee basis. Vendors must include all shipping and delivery costs in their proposals and comply with commercial general liability, workers' compensation, and professional liability insurance requirements. The procurement carried potential FEMA funding, which introduced supplemental federal compliance obligations. Recent state and local activity under this code appears sparse; the source does not identify other jurisdictions or opportunities soliciting naloxone or deactivation systems under this classification.